About
Sam Sharifi, PhD, is a biogerontologist and scientific founder focused on genome integrity, aging biology, and therapeutic translation. He is Chief Scientific Officer and co-founder of Matter Bio and is also publicly associated as a co-founder/CSO of Mutagentech and Loki Therapeutics. Earlier in his career he worked at Vincere Biosciences and the Leibniz Institute on Aging, and he co-authored longevity research including DrugAge.
Areas of interest
longevitybiotechaging researchgenome integrityepigeneticsmetabolismRNA biologyDNA biologygenomicsDNA repaircancer therapeuticsimmuno-oncology